SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

HST Global, Inc. – ‘10-Q’ for 6/30/22 – ‘XML’

On:  Tuesday, 7/26/22, at 3:32pm ET   ·   For:  6/30/22   ·   Accession #:  1674796-22-12   ·   File #:  0-15303

Previous ‘10-Q’:  ‘10-Q’ on 4/29/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/4/22 for 9/30/22   ·   Latest:  ‘10-Q’ on 11/7/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/26/22  HST Global, Inc.                  10-Q        6/30/22   34:1M                                     M Filings LLC/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Hst Global, Inc. - Form 10-Q SEC Filing             HTML    211K 
 2: EX-31       Certification -- §302 - SOA'02 -- exhibit31-1       HTML     15K 
 3: EX-31       Certification -- §302 - SOA'02 -- exhibit31-2       HTML     15K 
 4: EX-32       Certification -- §906 - SOA'02 -- exhibit32-1       HTML     12K 
 5: EX-32       Certification -- §906 - SOA'02 -- exhibit32-2       HTML     12K 
11: R1          Document and Entity Information                     HTML     61K 
12: R2          Condensed Balance Sheets                            HTML     83K 
13: R3          Condensed Consolidated Statements of Operations     HTML     69K 
14: R4          Condensed Consolidated Statements of Stockholders'  HTML     38K 
                Deficit                                                          
15: R5          Condensed Consolidated Statements of Cash Flows     HTML     55K 
16: R6          Note 1 - Organization and Principal Activities      HTML     17K 
17: R7          Note 2 - Significant Accounting Policies            HTML     20K 
18: R8          Note 3 - Going Concern                              HTML     16K 
19: R9          Note 4 - Related Party Transactions                 HTML     17K 
20: R10         Note 5 - Subsequent Events                          HTML     14K 
21: R11         NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Basis of  HTML     14K 
                Presentation (Policies)                                          
22: R12         NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES:           HTML     14K 
                Accounting Method (Policies)                                     
23: R13         NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Use of    HTML     16K 
                Estimates (Policies)                                             
24: R14         NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Cash and  HTML     15K 
                Cash Equivalents (Policies)                                      
25: R15         NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Basic     HTML     16K 
                and Diluted Income (Loss) Per Share (Policies)                   
26: R16         NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES:           HTML     16K 
                Stock-Based Compensation (Policies)                              
27: R17         NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Fair      HTML     15K 
                Value of Financial Instruments (Policies)                        
28: R18         NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Recently  HTML     14K 
                Issued Accounting Pronouncements (Policies)                      
29: R19         Note 4 - Related Party Transactions (Details)       HTML     25K 
32: XML         IDEA XML File -- Filing Summary                      XML     49K 
30: XML         XBRL Instance -- hstc-20220630_htm                   XML    164K 
31: EXCEL       IDEA Workbook of Financial Reports                  XLSX     36K 
 6: EX-101.CAL  XBRL Calculations -- hstc-20220630_cal               XML     50K 
 7: EX-101.DEF  XBRL Definitions -- hstc-20220630_def                XML     52K 
 8: EX-101.LAB  XBRL Labels -- hstc-20220630_lab                     XML    203K 
 9: EX-101.PRE  XBRL Presentations -- hstc-20220630_pre              XML    162K 
10: EX-101.SCH  XBRL Schema -- hstc-20220630                         XSD     40K 
33: JSON        XBRL Instance as JSON Data -- MetaLinks              106±   149K 
34: ZIP         XBRL Zipped Folder -- 0001674796-22-000012-xbrl      Zip     46K 


‘XML’   —   XBRL Instance — hstc-20220630_htm


This Document is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:fil="http://www.hstglobal.com/20220630" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="hstc-20220630.xsd" xlink:type="simple"/>
<context id="D220101_220630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="E22Q2">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="I220726">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
</entity>
<period>
<instant> 2022-07-26 </instant>
</period>
</context>
<context id="E21">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="Y22Q2">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="Y21Q2">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="D210101_210630">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="E20">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="E20_StEqComps-CommonStock">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="E20_StEqComps-AddPaidInCap">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="E20_StEqComps-RetainedEarnings">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="E20_StEqComps-Parent">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:ParentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="D210101_210330_StEqComps-CommonStock">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-30 </endDate>
</period>
</context>
<context id="D210101_210330_StEqComps-AddPaidInCap">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-30 </endDate>
</period>
</context>
<context id="D210101_210330_StEqComps-RetainedEarnings">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-30 </endDate>
</period>
</context>
<context id="D210101_210330_StEqComps-Parent">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:ParentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-30 </endDate>
</period>
</context>
<context id="Y21Q2_StEqComps-CommonStock">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="Y21Q2_StEqComps-AddPaidInCap">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="Y21Q2_StEqComps-RetainedEarnings">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="Y21Q2_StEqComps-Parent">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:ParentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="E21Q2">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="E21Q2_StEqComps-CommonStock">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="E21Q2_StEqComps-AddPaidInCap">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="E21Q2_StEqComps-RetainedEarnings">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="E21Q2_StEqComps-Parent">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:ParentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="E21_StEqComps-CommonStock">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="E21_StEqComps-AddPaidInCap">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="E21_StEqComps-RetainedEarnings">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="E21_StEqComps-Parent">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:ParentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="D220101_220330_StEqComps-CommonStock">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-30 </endDate>
</period>
</context>
<context id="D220101_220330_StEqComps-AddPaidInCap">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-30 </endDate>
</period>
</context>
<context id="D220101_220330_StEqComps-RetainedEarnings">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-30 </endDate>
</period>
</context>
<context id="D220101_220330_StEqComps-Parent">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:ParentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-30 </endDate>
</period>
</context>
<context id="Y22Q2_StEqComps-CommonStock">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="Y22Q2_StEqComps-AddPaidInCap">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="Y22Q2_StEqComps-RetainedEarnings">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="Y22Q2_StEqComps-Parent">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:ParentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="E22Q2_StEqComps-CommonStock">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="E22Q2_StEqComps-AddPaidInCap">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="E22Q2_StEqComps-RetainedEarnings">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="E22Q2_StEqComps-Parent">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:ParentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="D220101_220630_RelPtyTrn-NotesPayRelatedParties">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> fil:NotesPayableRelatedPartiesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="D220101_220630_RelPtyTrn-ExecutiveOffices">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> fil:ExecutiveOfficesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="D220101_220630_RelPtyTrn-HowellConsultingAgreement">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> fil:HowellConsultingAgreementMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="E21_RelPtyTrn-HowellConsultingAgreement">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> fil:HowellConsultingAgreementMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="E22Q2_RelPtyTrn-HowellConsultingAgreement">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000797564 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> fil:HowellConsultingAgreementMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<unit id="USD">
<measure> iso4217:USD </measure>
</unit>
<unit id="Shares">
<measure> shares </measure>
</unit>
<unit id="UsdPerShare">
<divide>
<unitNumerator>
<measure> iso4217:USD </measure>
</unitNumerator>
<unitDenominator>
<measure> shares </measure>
</unitDenominator>
</divide>
</unit>
<dei:EntityCentralIndexKey contextRef="D220101_220630" id="fact1"> 0000797564 </dei:EntityCentralIndexKey>
<dei:CurrentFiscalYearEndDate contextRef="D220101_220630" id="fact2"> --12-31 </dei:CurrentFiscalYearEndDate>
<dei:EntityEmergingGrowthCompany contextRef="D220101_220630" id="fact3"> true </dei:EntityEmergingGrowthCompany>
<dei:EntitySmallBusiness contextRef="D220101_220630" id="fact4"> true </dei:EntitySmallBusiness>
<dei:EntityExTransitionPeriod contextRef="D220101_220630" id="fact5"> false </dei:EntityExTransitionPeriod>
<dei:EntityShellCompany contextRef="D220101_220630" id="fact6"> false </dei:EntityShellCompany>
<dei:AmendmentFlag contextRef="D220101_220630" id="fact7"> false </dei:AmendmentFlag>
<dei:DocumentFiscalYearFocus contextRef="D220101_220630" id="fact8"> 2022 </dei:DocumentFiscalYearFocus>
<dei:DocumentFiscalPeriodFocus contextRef="D220101_220630" id="fact9"> Q2 </dei:DocumentFiscalPeriodFocus>
<dei:DocumentQuarterlyReport contextRef="D220101_220630" id="fact10"> true </dei:DocumentQuarterlyReport>
<dei:DocumentTransitionReport contextRef="D220101_220630" id="fact11"> false </dei:DocumentTransitionReport>
<dei:DocumentType contextRef="D220101_220630"> 10-Q </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="D220101_220630"> 2022-06-30 </dei:DocumentPeriodEndDate>
<dei:EntityFileNumber contextRef="D220101_220630"> 000-15303 </dei:EntityFileNumber>
<dei:EntityRegistrantName contextRef="D220101_220630"> HST Global, Inc. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="D220101_220630"> NV </dei:EntityIncorporationStateCountryCode>
<dei:EntityTaxIdentificationNumber contextRef="D220101_220630"> 73-1215433 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="D220101_220630"> 150 Research Drive </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="D220101_220630"> Hampton </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="D220101_220630"> VA </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="D220101_220630"> 23666 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="D220101_220630"> 757 </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="D220101_220630"> 766-6100 </dei:LocalPhoneNumber>
<dei:EntityCurrentReportingStatus contextRef="D220101_220630"> Yes </dei:EntityCurrentReportingStatus>
<dei:EntityInteractiveDataCurrent contextRef="D220101_220630"> Yes </dei:EntityInteractiveDataCurrent>
<dei:EntityFilerCategory contextRef="D220101_220630"> Non-accelerated Filer </dei:EntityFilerCategory>
<dei:EntityCommonStockSharesOutstanding contextRef="I220726" decimals="INF" unitRef="Shares"> 5248582 </dei:EntityCommonStockSharesOutstanding>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="E22Q2" decimals="INF" unitRef="USD"> 365 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="E21" decimals="INF" unitRef="USD"> 225 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:AssetsCurrent contextRef="E22Q2" decimals="INF" unitRef="USD"> 365 </us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="E21" decimals="INF" unitRef="USD"> 225 </us-gaap:AssetsCurrent>
<us-gaap:Assets contextRef="E22Q2" decimals="INF" unitRef="USD"> 365 </us-gaap:Assets>
<us-gaap:Assets contextRef="E21" decimals="INF" unitRef="USD"> 225 </us-gaap:Assets>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="E22Q2" decimals="128" unitRef="USD"> 0 </us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="E21" decimals="128" unitRef="USD"> 0 </us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
<us-gaap:DueToRelatedPartiesCurrent contextRef="E22Q2" decimals="INF" unitRef="USD"> 302275 </us-gaap:DueToRelatedPartiesCurrent>
<us-gaap:DueToRelatedPartiesCurrent contextRef="E21" decimals="INF" unitRef="USD"> 242275 </us-gaap:DueToRelatedPartiesCurrent>
<us-gaap:DeferredCompensationLiabilityCurrent contextRef="E22Q2" decimals="INF" unitRef="USD"> 67077 </us-gaap:DeferredCompensationLiabilityCurrent>
<us-gaap:DeferredCompensationLiabilityCurrent contextRef="E21" decimals="INF" unitRef="USD"> 55077 </us-gaap:DeferredCompensationLiabilityCurrent>
<us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="E22Q2" decimals="INF" unitRef="USD"> 5523 </us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
<us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="E21" decimals="INF" unitRef="USD"> 3656 </us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
<us-gaap:LiabilitiesCurrent contextRef="E22Q2" decimals="INF" unitRef="USD"> 374875 </us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="E21" decimals="INF" unitRef="USD"> 301008 </us-gaap:LiabilitiesCurrent>
<us-gaap:Liabilities contextRef="E22Q2" decimals="INF" unitRef="USD"> 374875 </us-gaap:Liabilities>
<us-gaap:Liabilities contextRef="E21" decimals="INF" unitRef="USD"> 301008 </us-gaap:Liabilities>
<us-gaap:PreferredStockValue contextRef="E22Q2" decimals="128" unitRef="USD"> 0 </us-gaap:PreferredStockValue>
<us-gaap:PreferredStockValue contextRef="E21" decimals="128" unitRef="USD"> 0 </us-gaap:PreferredStockValue>
<us-gaap:CommonStockValue contextRef="E22Q2" decimals="INF" unitRef="USD"> 5248 </us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="E21" decimals="INF" unitRef="USD"> 5248 </us-gaap:CommonStockValue>
<us-gaap:AdditionalPaidInCapital contextRef="E22Q2" decimals="INF" unitRef="USD"> 5417236 </us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="E21" decimals="INF" unitRef="USD"> 5417236 </us-gaap:AdditionalPaidInCapital>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="E22Q2" decimals="INF" unitRef="USD"> -5796994 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="E21" decimals="INF" unitRef="USD"> -5723267 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockholdersEquity contextRef="E22Q2" decimals="INF" unitRef="USD"> -374510 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="E21" decimals="INF" unitRef="USD"> -300783 </us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="E22Q2" decimals="INF" unitRef="USD"> 365 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="E21" decimals="INF" unitRef="USD"> 225 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:Revenues contextRef="Y22Q2" decimals="128" unitRef="USD"> 0 </us-gaap:Revenues>
<us-gaap:Revenues contextRef="Y21Q2" decimals="128" unitRef="USD"> 0 </us-gaap:Revenues>
<us-gaap:Revenues contextRef="D220101_220630" decimals="128" unitRef="USD"> 0 </us-gaap:Revenues>
<us-gaap:Revenues contextRef="D210101_210630" decimals="128" unitRef="USD"> 0 </us-gaap:Revenues>
<us-gaap:LaborAndRelatedExpense contextRef="Y22Q2" decimals="INF" unitRef="USD"> 30000 </us-gaap:LaborAndRelatedExpense>
<us-gaap:LaborAndRelatedExpense contextRef="Y21Q2" decimals="INF" unitRef="USD"> 30000 </us-gaap:LaborAndRelatedExpense>
<us-gaap:LaborAndRelatedExpense contextRef="D220101_220630" decimals="INF" unitRef="USD"> 60000 </us-gaap:LaborAndRelatedExpense>
<us-gaap:LaborAndRelatedExpense contextRef="D210101_210630" decimals="INF" unitRef="USD"> 60000 </us-gaap:LaborAndRelatedExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Y22Q2" decimals="INF" unitRef="USD"> 4527 </us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Y21Q2" decimals="INF" unitRef="USD"> 8217 </us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="D220101_220630" decimals="INF" unitRef="USD"> 11860 </us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="D210101_210630" decimals="INF" unitRef="USD"> 16521 </us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:OperatingExpenses contextRef="Y22Q2" decimals="INF" unitRef="USD"> 34527 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Y21Q2" decimals="INF" unitRef="USD"> 38217 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="D220101_220630" decimals="INF" unitRef="USD"> 71860 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="D210101_210630" decimals="INF" unitRef="USD"> 76521 </us-gaap:OperatingExpenses>
<us-gaap:OperatingIncomeLoss contextRef="Y22Q2" decimals="INF" unitRef="USD"> -34527 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Y21Q2" decimals="INF" unitRef="USD"> -38217 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="D220101_220630" decimals="INF" unitRef="USD"> -71860 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="D210101_210630" decimals="INF" unitRef="USD"> -76521 </us-gaap:OperatingIncomeLoss>
<us-gaap:InterestExpense contextRef="Y22Q2" decimals="INF" unitRef="USD"> 986 </us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="Y21Q2" decimals="INF" unitRef="USD"> 662 </us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="D220101_220630" decimals="INF" unitRef="USD"> 1867 </us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="D210101_210630" decimals="INF" unitRef="USD"> 1097 </us-gaap:InterestExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Y22Q2" decimals="INF" unitRef="USD"> -986 </us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Y21Q2" decimals="INF" unitRef="USD"> -662 </us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="D220101_220630" decimals="INF" unitRef="USD"> -1867 </us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="D210101_210630" decimals="INF" unitRef="USD"> -1097 </us-gaap:NonoperatingIncomeExpense>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="Y22Q2" decimals="INF" unitRef="USD"> -35513 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="Y21Q2" decimals="INF" unitRef="USD"> -38879 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="D220101_220630" decimals="INF" unitRef="USD"> -73727 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="D210101_210630" decimals="INF" unitRef="USD"> -77618 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Y22Q2" decimals="128" unitRef="USD"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Y21Q2" decimals="128" unitRef="USD"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="D220101_220630" decimals="128" unitRef="USD"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="D210101_210630" decimals="128" unitRef="USD"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:NetIncomeLoss contextRef="Y22Q2" decimals="INF" unitRef="USD"> -35513 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Y21Q2" decimals="INF" unitRef="USD"> -38879 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="D220101_220630" decimals="INF" unitRef="USD"> -73727 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="D210101_210630" decimals="INF" unitRef="USD"> -77618 </us-gaap:NetIncomeLoss>
<us-gaap:EarningsPerShareBasic contextRef="Y22Q2" decimals="INF" unitRef="UsdPerShare"> -0.01 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareBasic contextRef="Y21Q2" decimals="INF" unitRef="UsdPerShare"> -0.01 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareBasic contextRef="D220101_220630" decimals="INF" unitRef="UsdPerShare"> -0.01 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareBasic contextRef="D210101_210630" decimals="INF" unitRef="UsdPerShare"> -0.01 </us-gaap:EarningsPerShareBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Y22Q2" decimals="INF" unitRef="Shares"> 5248582 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Y21Q2" decimals="INF" unitRef="Shares"> 5248582 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="D220101_220630" decimals="INF" unitRef="Shares"> 5248582 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="D210101_210630" decimals="INF" unitRef="Shares"> 5248582 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E20_StEqComps-CommonStock" decimals="INF" unitRef="USD"> 5249 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E20_StEqComps-AddPaidInCap" decimals="INF" unitRef="USD"> 5417236 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E20_StEqComps-RetainedEarnings" decimals="INF" unitRef="USD"> -5574908 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E20_StEqComps-Parent" decimals="INF" unitRef="USD"> -152423 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="D210101_210330_StEqComps-CommonStock" decimals="128" unitRef="USD"> 0 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="D210101_210330_StEqComps-AddPaidInCap" decimals="128" unitRef="USD"> 0 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="D210101_210330_StEqComps-RetainedEarnings" decimals="INF" unitRef="USD"> -38740 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="D210101_210330_StEqComps-Parent" decimals="INF" unitRef="USD"> -38740 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="Y21Q2_StEqComps-CommonStock" decimals="128" unitRef="USD"> 0 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="Y21Q2_StEqComps-AddPaidInCap" decimals="128" unitRef="USD"> 0 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="Y21Q2_StEqComps-RetainedEarnings" decimals="INF" unitRef="USD"> -38878 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="Y21Q2_StEqComps-Parent" decimals="INF" unitRef="USD"> -38878 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E21Q2_StEqComps-CommonStock" decimals="INF" unitRef="USD"> 5249 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E21Q2_StEqComps-AddPaidInCap" decimals="INF" unitRef="USD"> 5417236 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E21Q2_StEqComps-RetainedEarnings" decimals="INF" unitRef="USD"> -5652526 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E21Q2_StEqComps-Parent" decimals="INF" unitRef="USD"> -230041 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E21_StEqComps-CommonStock" decimals="INF" unitRef="USD"> 5248 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E21_StEqComps-AddPaidInCap" decimals="INF" unitRef="USD"> 5417236 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E21_StEqComps-RetainedEarnings" decimals="INF" unitRef="USD"> -5723267 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E21_StEqComps-Parent" decimals="INF" unitRef="USD"> -300783 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="D220101_220330_StEqComps-CommonStock" decimals="128" unitRef="USD"> 0 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="D220101_220330_StEqComps-AddPaidInCap" decimals="128" unitRef="USD"> 0 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="D220101_220330_StEqComps-RetainedEarnings" decimals="INF" unitRef="USD"> -38214 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="D220101_220330_StEqComps-Parent" decimals="INF" unitRef="USD"> -38214 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="Y22Q2_StEqComps-CommonStock" decimals="128" unitRef="USD"> 0 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="Y22Q2_StEqComps-AddPaidInCap" decimals="128" unitRef="USD"> 0 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="Y22Q2_StEqComps-RetainedEarnings" decimals="INF" unitRef="USD"> -35513 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest contextRef="Y22Q2_StEqComps-Parent" decimals="INF" unitRef="USD"> -35513 </us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E22Q2_StEqComps-CommonStock" decimals="INF" unitRef="USD"> 5248 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E22Q2_StEqComps-AddPaidInCap" decimals="INF" unitRef="USD"> 5417236 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E22Q2_StEqComps-RetainedEarnings" decimals="INF" unitRef="USD"> -5796994 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="E22Q2_StEqComps-Parent" decimals="INF" unitRef="USD"> -374510 </us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
<us-gaap:ProfitLoss contextRef="D220101_220630" decimals="INF" unitRef="USD"> -73727 </us-gaap:ProfitLoss>
<us-gaap:ProfitLoss contextRef="D210101_210630" decimals="INF" unitRef="USD"> -77618 </us-gaap:ProfitLoss>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="D220101_220630" decimals="128" unitRef="USD"> 0 </us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="D210101_210630" decimals="INF" unitRef="USD"> -4918 </us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInDeferredCompensation contextRef="D220101_220630" decimals="INF" unitRef="USD"> 60000 </us-gaap:IncreaseDecreaseInDeferredCompensation>
<us-gaap:IncreaseDecreaseInDeferredCompensation contextRef="D210101_210630" decimals="INF" unitRef="USD"> 60800 </us-gaap:IncreaseDecreaseInDeferredCompensation>
<us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="D220101_220630" decimals="INF" unitRef="USD"> 1867 </us-gaap:IncreaseDecreaseInInterestPayableNet>
<us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="D210101_210630" decimals="INF" unitRef="USD"> 1097 </us-gaap:IncreaseDecreaseInInterestPayableNet>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="D220101_220630" decimals="INF" unitRef="USD"> -11860 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="D210101_210630" decimals="INF" unitRef="USD"> -20639 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="D220101_220630" decimals="128" unitRef="USD"> 0 </us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="D210101_210630" decimals="128" unitRef="USD"> 0 </us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:ProceedsFromRelatedPartyDebt contextRef="D220101_220630" decimals="INF" unitRef="USD"> 12000 </us-gaap:ProceedsFromRelatedPartyDebt>
<us-gaap:ProceedsFromRelatedPartyDebt contextRef="D210101_210630" decimals="INF" unitRef="USD"> 21100 </us-gaap:ProceedsFromRelatedPartyDebt>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="D220101_220630" decimals="INF" unitRef="USD"> 12000 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="D210101_210630" decimals="INF" unitRef="USD"> 21100 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="D220101_220630" decimals="INF" unitRef="USD"> 140 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="D210101_210630" decimals="INF" unitRef="USD"> 461 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="E21" decimals="INF" unitRef="USD"> 225 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="E20" decimals="INF" unitRef="USD"> 660 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="E22Q2" decimals="INF" unitRef="USD"> 365 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="E21Q2" decimals="INF" unitRef="USD"> 1121 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:InterestPaid contextRef="D220101_220630" decimals="128" unitRef="USD"> 0 </us-gaap:InterestPaid>
<us-gaap:InterestPaid contextRef="D210101_210630" decimals="128" unitRef="USD"> 0 </us-gaap:InterestPaid>
<us-gaap:IncomeTaxesPaid contextRef="D220101_220630" decimals="128" unitRef="USD"> 0 </us-gaap:IncomeTaxesPaid>
<us-gaap:IncomeTaxesPaid contextRef="D210101_210630" decimals="128" unitRef="USD"> 0 </us-gaap:IncomeTaxesPaid>
<us-gaap:NatureOfOperations contextRef="D220101_220630">
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><b>NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES </b></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">HST Global, Inc. (the "Company") was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company has made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition has been accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations.  Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company is currently headquartered in Hampton, Virginia.</p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;text-align:justify">HST Global, Inc. was founded as an Integrated Health and Wellness Biotechnology company with a plan to develop and /or acquire a network of Wellness Centers worldwide that would be primarily focused on the homeopathic and alternative treatment of late stage cancer. </p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;text-align:justify">To date we have been unable to initiate our original business plan.  While we are continuing to seek opportunities to do so, we are also seeking other opportunities to integrate assets, rights, or other potential revenue streams.</p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The accompanying interim financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and footnotes necessary for a complete presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature. The unaudited quarterly financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K of the Company as of and for the fiscal year ended December 31, 2021. The results of operations for the period ended June 30, 2022, are not necessarily indicative of the results for a full-year period.</p>
</us-gaap:NatureOfOperations>
<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="D220101_220630">
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES</b></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Basis of Presentation</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The accompanying financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K and 10-Q.  </p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Accounting Method </span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The Company’s financial statements are prepared using the accrual method of accounting.  The Company has elected a December 31 year-end.</p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Use of Estimates</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and </p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify"><span style="font-family:Times New Roman">liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Cash and Cash Equivalents</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents.</p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify"><span style="border-bottom:1px solid #000000">Basic and Diluted Income (Loss) Per Share</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. </p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Stock-Based Compensation</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The Company adopted ASC 718, <i>“Stock Compensation”</i>. Under ASC 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the income statement based on their fair values. As of  June 30, 2022, the Company has not issued any employer stock options.</p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Fair Value of Financial Instruments</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The Company adopted ASC 820 which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value.</p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis. </p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Recently Issued Accounting Pronouncements</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.</p>
</us-gaap:SignificantAccountingPoliciesTextBlock>
<us-gaap:BasisOfAccounting contextRef="D220101_220630">
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Basis of Presentation</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The accompanying financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K and 10-Q.  </p>
</us-gaap:BasisOfAccounting>
<us-gaap:RevenueRecognitionPolicyTextBlock contextRef="D220101_220630">
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Accounting Method </span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The Company’s financial statements are prepared using the accrual method of accounting.  The Company has elected a December 31 year-end.</p>
</us-gaap:RevenueRecognitionPolicyTextBlock>
<us-gaap:UseOfEstimates contextRef="D220101_220630">
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Use of Estimates</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and </p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify"><span style="font-family:Times New Roman">liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p>
</us-gaap:UseOfEstimates>
<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="D220101_220630">
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Cash and Cash Equivalents</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents.</p>
</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
<us-gaap:EarningsPerSharePolicyTextBlock contextRef="D220101_220630">
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify"><span style="border-bottom:1px solid #000000">Basic and Diluted Income (Loss) Per Share</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. </p>
</us-gaap:EarningsPerSharePolicyTextBlock>
<us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="D220101_220630">
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Stock-Based Compensation</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The Company adopted ASC 718, <i>“Stock Compensation”</i>. Under ASC 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the income statement based on their fair values. As of  June 30, 2022, the Company has not issued any employer stock options.</p>
</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="D220101_220630">
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Fair Value of Financial Instruments</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The Company adopted ASC 820 which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value.</p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis. </p>
</us-gaap:FairValueOfFinancialInstrumentsPolicy>
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="D220101_220630">
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Recently Issued Accounting Pronouncements</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.</p>
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="D220101_220630">
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><b>NOTE 3 – GOING CONCERN</b></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern for a period of one year from the issuance of these financial statements. The ability of the Company to continue as a going concern is dependent on the Company </p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify"><span style="font-family:Times New Roman">obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.  These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">Management’s plan to support the Company in its operations and to maintain its business strategy is to raise funds through public offerings and to rely on officers and directors to perform essential functions with minimal compensation. If the Company does not raise all of the money it needs from public offerings, it will have to find alternative sources, such as a second public offering, a private placement of securities, or loans from its officers, directors or others. If the Company requires additional cash and is unable to raise it, it will either have to suspend operations until the cash is raised, or cease business entirely.</p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p>
</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="D220101_220630">
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><b>NOTE 4 – RELATED PARTY TRANSACTIONS</b></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Notes Payable – Related Parties</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000">During the six months ended June 30, 2022, the Company received $12,000 in additional cash loans from Ronald R. Howell. Interest is accrued at 6% annually and the note has a $67,077 outstanding balance as of June 30, 2022. </p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Executive Offices</span></p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000">The Company’s executive offices are located at 150 Research Dr., Hampton VA.  These offices are leased by The Health Network, Inc. (“HTN”), of which Ron Howell is President.  THN allows the Company to use the office space without a formal sublease or rental agreement. </p> <p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Consulting Agreements</span></p> <p style="font:11pt Times New Roman;margin:0;color:#000000">The Company has entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services through December 31, 2010.  The Company had agreed to continue to<b> </b>engage Mr. Howell as a consultant until his consulting services are no longer required.  As of December 31, 2021, the Company owed Mr. Howell $240,000 under the consulting agreement.  As of June 30, 2022, the Company owed Mr. Howell $300,000 under the consulting agreement.</p>
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="D220101_220630_RelPtyTrn-NotesPayRelatedParties"> During the six months ended June 30, 2022, the Company received $12,000 in additional cash loans from Ronald R. Howell. Interest is accrued at 6% annually and the note has a $67,077 outstanding balance as of June 30, 2022. </us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
<us-gaap:IncreaseDecreaseInDueToRelatedParties contextRef="D220101_220630_RelPtyTrn-NotesPayRelatedParties" decimals="INF" unitRef="USD"> 12000 </us-gaap:IncreaseDecreaseInDueToRelatedParties>
<us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="D220101_220630_RelPtyTrn-ExecutiveOffices"> THN allows the Company to use the office space without a formal sublease or rental agreement. </us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
<us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="D220101_220630_RelPtyTrn-HowellConsultingAgreement"> The Company has entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services </us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
<us-gaap:DeferredCompensationLiabilityCurrent contextRef="E21_RelPtyTrn-HowellConsultingAgreement" decimals="INF" unitRef="USD"> 240000 </us-gaap:DeferredCompensationLiabilityCurrent>
<us-gaap:DeferredCompensationLiabilityCurrent contextRef="E22Q2_RelPtyTrn-HowellConsultingAgreement" decimals="INF" unitRef="USD"> 300000 </us-gaap:DeferredCompensationLiabilityCurrent>
<us-gaap:SubsequentEventsTextBlock contextRef="D220101_220630">
<p style="font:11pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify"><b>NOTE 5 – SUBSEQUENT EVENTS</b></p> <p style="font:11pt Times New Roman;margin:0;color:#000000">In accordance with ASC 855, Company management reviewed all material events through the date of this report and determined that there are no other subsequent events to report.</p> <p style="font:11pt Times New Roman;margin:0;color:#000000"> </p>
</us-gaap:SubsequentEventsTextBlock>
</xbrl>

Top
Filing Submission 0001674796-22-000012   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 11:39:04.1am ET